J Biol Chem, Vol. 274, Issue 40, 28213-28218, October 1, 1999
Formation of 14,15-Hepoxilins of the A3 and
B3 Series through a 15-Lipoxygenase and Hydroperoxide
Isomerase Present in Garlic Roots*
Denis
Reynaud
,
Muslim
Ali§,
Peter
Demin
, and
Cecil R.
Pace-Asciak
¶
From the
Research Institute, The Hospital for Sick
Children, Toronto, Canada M5G 1X8, the § Department of
Biochemistry, Faculty of Science, Kuwait University, 13060 Safat,
Kuwait, and the ¶ Department of Pharmacology, Faculty of Medicine,
University of Toronto, Toronto, Ontario, Canada M5A 1S8
 |
ABSTRACT |
We report herein for the first time
the formation by freshly grown garlic roots and the structural
characterization of 14,15-epoxide positional analogs of the hepoxilins
formed via the 15-lipoxygenase-induced oxygenation of arachidonic acid.
These compounds are formed through the combined actions of a
15(S)-lipoxygenase and a hydroperoxyeicosatetraenoic acid
(HPETE) isomerase. The compounds were formed when either arachidonic
acid or 15-HPETE were used as substrates. Both the "A"-type and the
"B"-type products are formed although the B-type compounds are
formed in greater relative quantities. Chiral phase high performance
liquid chromatography analysis confirmed the formation of hepoxilins
from 15(S)- but not 15(R)-HPETE, indicating high stereoselectivity of the isomerase. Additionally, the lipoxygenase was of the 15(S)-type as only
15(S)-hydroxyeicosatetraenoic acid was formed when
arachidonic acid was used as substrate. The structures of the products
were confirmed by gas chromatography-mass spectrometry of the methyl
ester trimethylsilyl ether derivatives as well as after characteristic
epoxide ring opening catalytically with hydrogen leading to dihydroxy
products. That 15(S)-lipoxygenase activity is of functional
importance in garlic was shown by the inhibition of root growth by BW
755C, a dual cyclooxygenase/lipoxygenase inhibitor and
nordihydroguaiaretic acid, a lipoxygenase inhibitor. Additional
biological studies were carried out with the purified intact
14(S),15(S)-hepoxilins, which were investigated
for hepoxilin-like actions in causing the release of intracellular
calcium in human neutrophils. The 14,15-hepoxilins
dose-dependently caused a rise in cytosolic calcium, but
their actions were 5-10-fold less active than
11(S),12(S)-hepoxilins derived from
12(S)-HPETE. These studies provide evidence that
15(S)-lipoxygenase is functionally important to normal root
growth and that HPETE isomerization into the hepoxilin-like structure
may be ubiquitous; the hepoxilin-evoked release of calcium in human
neutrophils, which is receptor-mediated, is sensitive to the location
within the molecule of the hydroxyepoxide functionality.
 |
INTRODUCTION |
Hepoxilins (11(S),12(S)-type) are formed
through the coupling of a 12(S)-lipoxygenase and a
12(S)-HPETE1
isomerase (hepoxilin synthase) discovered in the rat pancreatic islets
of Langerhans (1, 2), the pineal gland (3), and brain (4-6). They have
been shown to exert a variety of biological actions likely mediated via
their actions on ion fluxes, namely calcium (5, 7-11) and potassium
(12, 13) within the cell. The hepoxilins cause the release of insulin
(14), potentiate vascular contraction (15, 16), block neurotransmitter
release (17), regulate cell volume (12), and provoke skin vascular permeability (18). Hepoxilin actions, at least in the human neutrophil,
have been shown to be mediated via a hepoxilin-specific receptor (19,
20). In an attempt to learn more about the enzymatic formation of the
hepoxilins, we investigated other sources for the "hepoxilin
synthase" which may provide an abundant supply for the purification
of the enzyme. Herein, we report the formation of hepoxilins via the
15-lipoxygenase pathway which is abundant in freshly grown roots of
garlic. The isolated compounds (14,15-hepoxilins) constitute structural
analogs of the parent 11,12-hepoxilins and provide further information
on the specificity of the hepoxilin receptor in human neutrophils
toward hepoxilins derived from 12-lipoxygenase.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Garlic bulbs were purchased from a local grocery
store. They were placed individually in glass beakers in contact with
tap water for 2-3 weeks until sufficient roots emerged, water being changed every day. The roots were cut off, rinsed with tap water and
stored at
70o until enough tissue was collected for the
experiments. Ionomycin, Dextran T-500, and Ficoll-Paque were purchased
from Amersham Pharmacia Biotech, Sweden, and Indo-1-AM from Calbiochem.
ADAM reagent was purchased from Research Organics Inc., Cleveland,
Ohio. Racemic 15(S/R)-HPETE was prepared by
photo-oxidation as described previously for
12(S/R)-HPETE (3). RPMI 1640 medium, hemin
(bovine), and all reagent grade chemicals for buffers and NDGA were
purchased from Sigma. BW 755C was a gift of Dr. Salvador Moncada
(Burroughs-Wellcome, UK).
Incubations--
Separate incubations were carried out with
arachidonic acid (Cayman Chemical Co., Ann Arbor, MI) or with
15(S/R)-HPETE as substrates. Typically, 1 g
of garlic roots was homogenized in 2 ml of phosphate-buffered saline of
the following composition: NaCl (140 mM),
NaH2PO4 (10 mM), and
Na2HPO4 (10 mM), pH 7.2. The homogenate was centrifuged at 2000 rpm for 5 min, and 400-µl aliquots were added to siliconized tubes containing either arachidonic acid (1 µg) or 15(S/R)-HPETE (1 µg) and made up with
buffer to a total volume of 1 ml. The samples were incubated at
37 °C for 60 min. The incubation was terminated by cooling on ice
and addition of 1 ml of methanol and 2 ml of ethyl acetate containing
ADAM reagent (140 µg/sample). The samples were stirred at 23 °C in the dark for 60 min to form the ADAM esters, and the ethyl acetate phase was separated and evaporated to complete dryness with a stream of
N2 gas. The residue containing the ADAM esters of the products was analyzed directly by HPLC. To generate standards of
14,15-hepoxilins, 15(S/R)-HPETE (1 µg) was
treated in phosphate-buffered saline containing hemin (10 µg) for 60 min and worked up as with the garlic root incubations.
HPLC Analysis--
The ADAM derivatives of the incubates were
analyzed by HPLC on different columns using the intrinsic fluorescence
of ADAM esters (mercury lamp with cut-off filters at 254 nm excitation and 400 nm emission) and an on-line fluorescent detector (Kratos) as
described previously (21). First, the crude samples were analyzed by
reverse phase-HPLC on a Nova-Pak C18 column (Waters Corp. Milford, MA,
3.9 × 300 mm) using acetonitrile/water (75/25, v/v, flow rate 1.5 ml/min) as running solvent. The appropriate fractions in which the
14,15-hepoxilin metabolites (A3 and B3) were
eluted, as well as the fractions containing 15-HETE, were collected.
These fractions were further analyzed and purified by SP-HPLC on a
µPorasil column (Waters Corp., 3.9 × 300 mm) using hexane/isopropanol (99.3/0.7, v/v, flow rate 2 ml/min). The purified 15-HETE and 14,15-hepoxilin A3 and B3 fractions
were next separately analyzed on chiral phase HPLC using a Chiralcel-OD
(J. T. Baker, Phillipsburg, NJ, 4.6 × 250 mm, flow rate 1.5 ml/min) column eluted isocratically with hexane/isopropanol (96/4, v/v)
for 15-HETE and hexane/isopropanol (95/5, v/v) for the 14,15-hepoxilins
(22).
GCMS--
Samples were analyzed as the MeTMSi derivatives in the
EI mode. Because the ADAM esters of the metabolites are unsuitable for
hydrolysis and conversion into the methyl ester form for GCMS analysis,
separate large scale experiments using 100 µg of 15-HPETE were
performed in which the crude ethyl acetate extracts were converted
directly into the methyl ester form (instead of the ADAM esters) with a
solution of ethereal diazomethane. The methyl esters were then purified
by SP-HPLC on a µPorasil column (hexane/isopropanol 99.7/0.3, v/v,
detection 210 nm). The purified fractions were converted into the TMSi
ether derivatives by reaction with TriSilZ (Chromatographic
Specialties, Brockville, Ontario, Canada, 20 µl), 5 min at 60 °C.
Aliquots were injected into the GCMS directly. Samples were also
analyzed after hydrogenation (platinum oxide/methanol, 30 s) of
the methyl esters and subsequent conversion into the TMSi ether
derivatives. A DB-1 methyl silicone capillary column (Chromatographic
Specialties, Brockville, Ontario, Canada, 30 m length × 0.25 mm
ID, 0.25 µm film thickness) was used; the column temperature was
programmed from 200 °C initially to 300 °C at 10 °C/min.
Measurement of Intracellular Free Calcium--
Neutrophils were
prepared according to procedures previously published by our group (7).
Intracellular free calcium concentrations were monitored continuously
in a Perkin-Elmer fluorescence spectrophotometer (Model 650-40) using
Indo-1-AM-loaded neutrophils. Excitation wavelength was set at 331 nm
and emission wavelength at 410 nm, with slits of excitation and
emission set at 3 and 15 nm, respectively. Neutrophil suspensions
(107 cells) were loaded with 3 µl of 1 mM
(final concentration 3 µM) of the acetoxymethyl ester
precursor of Indo-1 for 30 min at 37 °C. Unloaded dye was removed by
centrifugation, and the cells were resuspended in fresh RPMI 1640 (1 ml). Dye-loaded cells were kept at room temperature on a rotator
(Roto-Torque, Cole-Palmer model 7637, USA) turning at about 10-15
rotations/min. Typical measurements involved 2 × 106
cells in 1 ml of cell medium in a temperature controlled plastic cuvette (Diamed Labs., Canada) at 37 °C with constant stirring. Compounds were added in 1 µl of Me2SO. Each measurement
was followed by a calibration for maximum and minimum calcium release
with ionomycin (1 µM final concentration) and
MnCl2 (3 mM final concentration), respectively,
according to Grinstein and Furuya (23). Responses were recorded on a
chart recorder (LKB model 2210, Amersham Pharmacia Biotech, Sweden) at
1 cm/min chart speed.
Measurement of Garlic Root Growth--
Garlic bulbs were
purchased from a local grocery store, care being taken to select bulbs
of similar weight and size. They were cleaned and placed on glass
beakers (one/beaker) filled with tap water (100 ml) with the bottom of
the bulb touching the water. Four groups of 6 bulbs/group were set up.
Two groups contained the two inhibitors which were dissolved in
Me2SO and added to selected containers at a final
concentration of 4 mg/100 ml. Two other groups contained only
Me2SO and served as control. The water was replaced every
third day for two weeks. At the end of the study period, the roots were
cut off with scissors, dried on paper, and weighed.
 |
RESULTS AND DISCUSSION |
Incubation of arachidonic acid with a cell-free homogenate of
garlic roots caused the formation of products that migrated on reverse
phase-HPLC after conversion into fluorescent ADAM derivatives as
characteristic doublets (19.4, 20.4, and 21.5, 22.1 min, Fig. 1E) in a region where
authentic 11,12-hepoxilins A3 and B3 migrate (doublets at 23.0, 23.9 min for the two epimers of HxA3 and
25.5, 26.3 for HxB3, Fig. 1A). Hence, the
pattern and relative elution of these products indicated that they were
hepoxilin-like products (Fig. 1). Further confirmation of the
hepoxilin-like nature of these compounds was obtained by their
disappearance from the chromatograms after treatment of the samples
with acid (data not shown). Arachidonic acid comprises approximately
2% of the fatty acids in garlic roots and approximately 5% in garlic
bulbs.2 Previous studies had
shown that an active 15-lipoxygenase was present in garlic roots (24)
and suggested therefore that the new products may be derived from this
pathway. In fact, when 15-HPETE was incubated with a garlic root
cell-free homogenate, products similar to those formed from arachidonic
acid were observed (compare Fig. 1, D and E).
Identical products were also formed when 15-HPETE was incubated with
hemin (in the absence of tissue, Fig. 1C), a condition
previously shown by us to lead, in the 12-HPETE series, to the
formation of 11(S),12(S)- and
11(R),12(R)-hepoxilins A3 and
B3.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 1.
Reverse phase-HPLC profiles of experiments in which
a cell-free homogenate of freshly grown garlic roots was incubated with
arachidonic acid (AA) (panel E), or
15(S/R)-HPETE (panel D). Also shown
are chromatograms from samples in which
15(S/R)-HPETE was incubated with hemin only
(panel C) and garlic root homogenate incubated without any
substrate (panel B). Authentic 11,12-hepoxilins derived from
12(S)-lipoxygenase are shown in panel A. Products
were analyzed as ADAM esters by fluorescence detection (see
"Experimental Procedures" for details).
|
|
Despite the nonenzymatic (hemin-catalyzed) conversion of 12-HPETE into
the hepoxilins, we have previously observed that an enzyme system
exists in the pineal gland which forms exclusively the
11(S),12(S)-hepoxilins (3). This was demonstrated
by the selective utilization of 12(S)- but not 12(R)-HPETE
during hepoxilin formation. In the present experiments, we employed a
similar approach with 15(S/R)-HPETE to
investigate whether a selective consumption of 15(S)-HPETE
could be observed during incubation with garlic root homogenates to
indicate the presence of an HPETE isomerase. Hence HPLC fractions
corresponding to 15-HETE and the 14,15-hepoxilins were isolated and
subjected to chiral phase analysis. Fig.
2 shows that garlic roots convert
arachidonic acid exclusively into the 15(S)-HETE which
accumulates in the incubation (Fig. 2D); conversely, when
15(S/R)-HPETE is used as substrate, the
15(S)-enantiomer is selectively consumed for further
conversion into hepoxilin products while the
15(R)-enantiomer remains unmetabolized (Fig. 2C).
When a nonselective reaction of 15-HPETE is carried out, as with hemin,
both 15(S)- and 15(R)-HETE are detected at the end of the incubation (Fig. 2B). These experiments indicate
the stereospecificity of 15-lipoxygenase in garlic roots as well as the
selective utilization of the 15(S)-enantiomer by HPETE
isomerase to form the 14,15-hepoxilins. Confirmation of these findings
was obtained when 14,15-hepoxilins were analyzed by chiral-phase HPLC. Fig. 3a shows that while
14,15-hepoxilin B3 (the major hepoxilin formed by garlic
roots) affords chiral specificity (compare panels C
and D) when an enzyme system is used, note that the
corresponding hepoxilin A3 does not appear to, as its
pattern is similar to that obtained during hemin catalysis (Fig.
3b).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
Chiral phase HPLC analysis of 15-HETE
fractions collected from the chromatograms in Fig. 1, after further
purification on SP-HPLC. Note the selective formation of
15(S)-HETE from the incubations of garlic roots with
arachidonic acid (AA) (panel D), indicating the
presence of a 15(S)-lipoxygenase. Also note in the
experiments with 15(S/R)-HPETE substrate that
both HETE enantiomers are present in the incubate when hemin
was used as catalyst (i.e. nonenzymatic reaction)
(panel B), whereas in the presence of garlic roots
only 15(R)-HETE accumulates (panel C),
indicating the selective utilization of the 15(S) enantiomer
of the racemic 15-HPETE substrate by the HPETE isomerase in the garlic
root system. Panel A shows the resolution of
15(S) and 15(R)-enantiomers of 15-HETE
substrate.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
a, chiral phase analysis of
14,15-hepoxilin B3 fractions isolated from Fig. 1 after
further purification on SP-HPLC. The panels are in the same order as in
Fig. 2. Note the stereoselective formation of the
14(S),15(S)-hepoxilin by the garlic root HPETE
isomerase (panels C and D) as compared with the
mixture of 14(S),15(S)- and
14(R),15(R)-stereoisomers during hemin catalysis
(panel B), confirming the data in Fig. 2 of the selective
utilization of 15(S)-HPETE in the enzymatic hepoxilin
formation. The data also indicate formation of hepoxilin from both
S- and R-enantiomers of 15-HPETE during
nonenzymatic catalysis. The resolution of authentic hepoxilin
B3 enantiomers of the 11,12-series is shown in panel
A for comparison. b, chiral phase analysis of
14,15-hepoxilin A3 fractions isolated from Fig. 1 after
further purification on SP-HPLC. The panels are in the same order as in
Figs. 2 and 3. In contrast to the highly stereoselective formation from
arachidonic acid (AA) and 15(S)-HPETE of the
14(S),15(S)-hepoxilin B3 (Fig. 3),
chiral phase analysis of the A-series appears to indicate that there is
no stereo-selection in its formation by the garlic root system.
|
|
Characterization of the products was achieved through GCMS analysis
both as the intact metabolites and after catalytic hydrogenation. Hydrogenation serves to stabilize the hepoxilin structure and leads to
characteristic reductive opening of the epoxide group depending on
whether the hydroxyl group is adjacent to it (B-like) or allylic to it
(A-like) (25). Fig. 4 compares the mass
spectrum of the two types of metabolites isolated from garlic roots;
the top panel shows the 14,15-hepoxilin B3 (Fig.
4A, Rt 16.5 min), and the lower panel shows the
spectrum of 14,15-hepoxilin A3 (Fig. 4C, Rt 17.3 min). Characteristic fragment ions in the spectra are:
m/z 332 (M-TMSiOH), 309 (C1-C13) (Fig.
4A); and m/z 422 (M+), 407 (M-15), 241 (C11-C20) (Fig. 4C). Selected ion chromatograms for these spectra are shown in the accompanying Figs. 4, B
and D. These spectra were identical to those of products
obtained during hemin catalysis of 15-HPETE (not shown). Catalytic
hydrogenation of these products gave a mixture of 13,14- and
13,15-dihydroxy-arachidic acid (Rt 12.1 min) derived from
14,15-hepoxilin B3 (Fig.
5A) and 11,15-dihydroxy-arachidic acid (Rt 12.6 min) derived from
14,15-hepoxilin A3 (Fig. 5C) with major
characteristic fragment ions at: m/z 315 (C1-C13, cleavage between two vicinal OH groups) and 173 (C15-C20) (Fig. 5A for the former product); and
m/z 173 (C15-C20), 317 (C11-C20), 287 (C1-C11)
(Fig. 5C for the latter product). Selected ion chromatograms for these spectra are shown in the accompanying Fig. 5, B
and D.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 4.
EI mass spectra of the isolated products as
methyl ester TMSi derivatives identified as 14,15-hepoxilin
B3 (panel A) with its
reconstructed ion chromatogram (panel B) and
14,15-hepoxilin A3 (panel C)
and its reconstructed ion chromatogram (panel
D).
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 5.
EI mass spectra of the isolated products
after catalytic hydrogenation (platinum oxide/methanol). The mass
spectra of hydrogenated products derived from 14,15-hepoxilin
B3 are shown in panels A (mass spectrum) and
B (reconstructed ion chromatogram) and of the hydrogenated
14,15-hepoxilin A3 in panels C (mass spectrum)
and D (reconstructed ion chromatogram).
|
|
The products isolated in this study are derived from activation of
15(S)-lipoxygenase (see Scheme
1). That this enzyme activity is of
importance to the rooting system of garlic was demonstrated by the
addition of two inhibitors of lipoxygenases, BW 755C and NDGA, prior to
initiation of rooting. Both inhibitors blocked the appearance of roots
which was abundant in the control groups (Fig.
6).

View larger version (16K):
[in this window]
[in a new window]
|
Scheme 1.
Pathway describing the formation by garlic
roots of the 14,15-hepoxilins isolated in this study.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
Inhibition of garlic root growth by BW 755C
and NDGA indicating an important function of
15(S)-lipoxygenase in garlic. Inhibitors were
added at the indicated final concentration in Me2SO.
Controls contain the same amount of Me2SO. The data refers
to the average weight of roots (mean ± SD, n = 6)
collected after 2 weeks of growth, the medium being changed every 3 days. Bars at the bottom show matched controls for each of the
inhibitors.
|
|
11(S),12(S)-Hepoxilin A3 has been
shown to evoke a dose-dependent rise in intracellular
calcium in human neutrophils (7, 9). We therefore examined the isolated
14,15-hepoxilins in this bioassay. Fig. 7
shows typical calcium profiles for the A-type and the B-type
14(S),15(S)-hepoxilins in comparison with the
profiles seen with the 11,12-type hepoxilins A3 and
B3 (top panels). It is clear that the
14,15-hepoxilins are able to dose-dependently cause a rise
in intracellular calcium although they are less active than
11,12-hepoxilin A3.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
Actions of the isolated
14(S),15(S)-hepoxilins as methyl
esters on intracellular calcium release in intact human neutrophils
loaded with INDO-1-AM fluorescent dye. The compounds were added to
neutrophil suspensions (see "Experimental Procedures" for details)
in 1 µl of Me2SO. The actions of the
11(S),12(S)-hepoxilins A3 and
B3 are shown. It is clear that the 14,15-hepoxilins are
active in this system although they appear somewhat weaker than
11,12-hepoxilin A3.
|
|
Garlic is widely used as a health supplement for a variety of
conditions. It has been reported to have anti-platelet (26, 27),
anti-cancer (28-30), and anti-atherogenic (31) properties although
active ingredients additional to the selenium-containing compounds,
allicin (32) and ajoene (32, 33), have not been systematically
investigated. A lipoxygenase pathway has recently been identified from
garlic with the isolation of some unique divinyl ether metabolites of
linoleic acid (34). The presence of a 15(S)-lipoxygenase in
garlic may afford relevance to atherosclerosis. Reported evidence
suggests that 15-lipoxygenase oxidizes LDL to a pro-atherogenic form
(35). However, evidence with transgenic rabbits that overexpress
15-lipoxygenase also indicates that these animals are resistant to the
development of atherosclerosis when fed a cholesterol-rich diet (36,
37). Hence 15-lipoxygenase may act in both a pro- and anti-atherogenic
manner depending on the time course of atherosclerosis (38). In the
early stages, 15-lipoxygenase may serve an anti-atherogenic role,
whereas in the later stages, it may act in a pro-atherogenic fashion
(39). The products described herein are major products derived from 15-lipoxygenase present in garlic. Their actions on neutrophils in
terms of intracellular calcium release may provide an insight into the
antiinflammatory actions of these compounds as hepoxilins derived from
the 12-lipoxygenase have been shown to inhibit the actions of
inflammatory mediators (9). Whether the anti-atherogenic actions of
garlic are related to the formation of the 14,15-hepoxilins remains to
be established.
In conclusion, we have demonstrated the presence in garlic roots of
15(S)-lipoxygenase activity, and this is coupled with an
HPETE isomerase (see Scheme 1). The products are analogs of the
11,12-hepoxilins that we described previously from the pancreas, pineal
gland, and brain formed through the enzymatic isomerization of
12(S)-HPETE. The present results show that
15(S)-lipoxygenase is functionally important to the rooting
system of garlic although we do not know whether the isolated
14,15-hepoxilins play a role. The present study also provides further
information into the structural specificity of the hepoxilin receptor
for 11,12-hepoxilin A3 in human neutrophils and the
potential ubiquity of the HPETE isomerase (or hepoxilin synthase).
 |
FOOTNOTES |
*
This work was supported by a grant from the Medical Research
Council of Canada (MT-4181) (to C. R. P.-A.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Research
Institute, Hospital for Sick Children, 555 University Ave., Toronto, Ontario, Canada M5G 1X8. Tel.: 416-813-5755; Fax: 416-813-5086; E-mail: pace@sickkids.on.ca.
2
D. Reynaud, M. Ali, P. Demin, and C. R. Pace-Asciak, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
HPETE, hydroperoxy-eicosatetraenoic acid;
HETE, hydroxy-eicosatetraenoic acid;
Hx, hepoxilin;
14,15-hepoxilin A3, 11-hydroxy-14,15-epoxyeicosa-5,8,12-trienoic acid;
14,15-hepoxilin
B3, 13-hydroxy-14,15-epoxyeicosa-5,8,11-trienoic acid;
ADAM, anthryl diazomethane;
Indo-1-AM, 1-[2-amino-5-(6-carboxyindole-2-yl)-phenoxy]-2-(2'-amino-5'-methylphenoxy)-ethane-N,N,N',N'-tetraacetic
acid pentaacetoxymethyl ester;
RPMI 1640, Roswell Park Memorial
Institute medium 1640;
GCMS, gas chromatography-mass spectrometry;
EI, electron impact;
HPLC, high performance liquid chromatography;
TMSi, trimethylsilyl ether;
BW 755C, (3-amino-1-(m-(trifluoromethyl-phenyl)-2-pyrazoline);
NDGA, nordihydroguaiaretic acid;
Rt, retention time.
 |
REFERENCES |
| 1.
|
Pace-Asciak, C. R.,
Martin, J. M.,
Corey, E. J.,
and Su, W.-G.
(1985)
Biochem. Biophys. Res. Commun.
128,
942-946[Medline]
[Order article via Infotrieve]
|
| 2.
|
Pace-Asciak, C. R.,
and Martin, J. M.
(1984)
Prostaglandins Leukotrienes Med.
16,
173-180[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Reynaud, D.,
Demin, P.,
and Pace-Asciak, C. R.
(1994)
J. Biol. Chem.
269,
23976-23980[Abstract/Free Full Text]
|
| 4.
|
Pace-Asciak, C. R.
(1988)
Biochem. Biophys. Res. Commun.
151,
493-498[Medline]
[Order article via Infotrieve]
|
| 5.
|
Piomelli, D.,
Shapiro, E.,
Zipkin, R.,
Schwartz, J. H.,
and Feinmark, S. J.
(1989)
Proc. Natl. Acad. Sci. (U. S. A.)
86,
1721-1725[Abstract/Free Full Text]
|
| 6.
|
Pace-Asciak, C. R.,
Laneuville, O.,
Su, W.-G.,
Corey, E. J.,
Gurevich, N.,
Wu, P.,
and Carlen, P. L.
(1990)
Proc. Natl. Acad. Sci. (U. S. A.)
87,
3037-3041[Abstract/Free Full Text]
|
| 7.
|
Dho, S.,
Grinstein, S.,
Corey, E. J.,
Su, W. G.,
and Pace-Asciak, C. R.
(1990)
Biochem. J.
266,
63-68[Medline]
[Order article via Infotrieve]
|
| 8.
|
Mills, L.,
Reynaud, D.,
and Pace-Asciak, C. R.
(1997)
Exp. Cell Res.
230,
337-341[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Laneuville, O.,
Reynaud, D.,
Grinstein, S.,
Nigam, S.,
and Pace-Asciak, C. R.
(1993)
Biochem. J.
295,
393-397
|
| 10.
|
Carlen, P. L.,
Gurevich, N.,
Zhang, L.,
Wu, P. H.,
Reynaud, D.,
and Pace-Asciak, C. R.
(1994)
Neuroscience
58,
493-502[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Carlen, P. L.,
Gurevich, N.,
Wu, P. H.,
Su, W.-G.,
Corey, E. J.,
and Pace-Asciak, C. R.
(1989)
Brain Res.
497,
171-176[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Margalit, A.,
Sofer, Y.,
Grossman, S.,
Reynaud, D.,
Pace-Asciak, C. R.,
and Livne, A.
(1993)
Proc. Natl. Acad. Sci. (U. S. A.)
90,
2589-2592[Abstract/Free Full Text]
|
| 13.
|
Belardetti, F.,
Campbell, W. B.,
Falck, J. R.,
Demontis, G.,
and Rosolowsky, M.
(1989)
Neuron
3,
497-505[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Pace-Asciak, C. R.,
Martin, J. M.,
and Corey, E. J.
(1986)
Prog. Lipid Res.
25,
625-628[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Laneuville, O.,
Couture, R.,
and Pace-Asciak, C. R.
(1992)
Br. J. Pharmacol.
107,
808-812[Medline]
[Order article via Infotrieve]
|
| 16.
|
Laneuville, O.,
Couture, R.,
and Pace-Asciak, C. R.
(1992)
Br. J. Pharmacol.
105,
297-304[Medline]
[Order article via Infotrieve]
|
| 17.
|
Pace-Asciak, C. R.,
Wong, L.,
and Corey, E. J.
(1990)
Biochem. Biophys. Res. Commun.
173,
949-953[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Laneuville, O.,
Corey, E. J.,
Couture, R.,
and Pace-Asciak, C. R.
(1991)
Eicosanoids
4,
95-97[Medline]
[Order article via Infotrieve]
|
| 19.
|
Reynaud, D.,
Demin, P.,
and Pace-Asciak, C. R.
(1995)
in
Mediators in the Cardiovascular System-Regional Ischemia
(Schrör, K.
, and Pace-Asciak, C. R., eds), Vol. 45
, pp. 291-296, Birkhauser Verlag, Basel, Switzerland
|
| 20.
|
Reynaud, D.,
Demin, P.,
and Pace-Asciak, C. R.
(1996)
Biochem. J.
313,
537-541
|
| 21.
|
Demin, P.,
Reynaud, D.,
and Pace-Asciak, C. R.
(1995)
Anal. Biochem.
226,
252-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Demin, P.,
Reynaud, D.,
and Pace-Asciak, C. R.
(1995)
J. Chromatogr. B.
672,
282-289[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Grinstein, S.,
and Furuya, W.
(1986)
Am. J. Physiol.
251,
C55-C65[Abstract/Free Full Text]
|
| 24.
|
Ali, M.,
Reynaud, D.,
and Pace-Asciak, C. R.
(1998)
in
Proceedings of the Fourth International Congress on Essential Fatty Acids and Eicosanoids, Edinburgh, 1998
(Riemersma, R. A.
, Armstrong, R. A.
, Kelly, R. W.
, and Wilson, R., eds)
, pp. 400-402, AOCS Press, Champaign, IL
|
| 25.
|
Pace-Asciak, C. R.,
Granström, E.,
and Samuelsson, B.
(1983)
J. Biol. Chem.
258,
6835-6840[Abstract/Free Full Text]
|
| 26.
|
Ali, M.,
Thomson, M.,
Alnaqeeb, M. A.,
Al-Hassan, J. M.,
Khater, S. H.,
and Gomes, S. A.
(1990)
Prostaglandins Leukotrienes Essent. Fatty Acids
41,
95-99[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Kakheja, A. N.,
and Bailey, J. M.
(1990)
Agents Actions
29,
360-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Singh, S. V.,
Mohan, R.,
Agarwal, R.,
Benson, P. J.,
Hu, X.,
Rudy, M. A.,
Xia, H.,
Katoh, A.,
Srivastava, S. K.,
Mukhtar, H.,
Gupta, V.,
and Zaren, H. A.
(1996)
Biochem. Biophys. Res. Commun.
225,
660-665[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Schaffer, E. M.,
Liu, J. Z.,
and Milner, J. A.
(1997)
Nutr. Cancer
27,
162-168[Medline]
[Order article via Infotrieve]
|
| 30.
|
Welch, C.,
Wuarin, L.,
and Sidell, N.
(1992)
Cancer Lett.
63,
211-219[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Evbuomwan, M. I.
(1992)
Med. Sci. Res.
20,
591-592
|
| 32.
|
Mayeux, P. R.,
Agrawal, K. C.,
Tou, J. S.,
King, B. T.,
Lippton, H. L.,
Hyman, A. L.,
Kadowitz, P. J.,
and McNamara, D. B.
(1988)
Agents Actions
25,
182-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Apitz-Castro, R.,
Escalante, J.,
Vargas, R.,
and Jain, M. K.
(1986)
Thromb. Res.
42,
303-311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Grechkin, A. N.,
Ilyasov, A. V.,
and Hamberg, M.
(1997)
Eur. J. Biochem.
245,
137-142[Medline]
[Order article via Infotrieve]
|
| 35.
|
Kuhn, H.,
Belkner, J.,
Suzuki, H.,
and Yamamoto, S.
(1994)
J. Lipid. Res.
35,
1749-1759[Abstract]
|
| 36.
|
Shen, J.,
Kuhn, H.,
Petho-Schramm, A.,
and Chan, L.
(1995)
FASEB J.
9,
1623-1631[Abstract]
|
| 37.
|
Shen, J.,
Herderick, E.,
Cornhill, J. F.,
Zsigmond, E.,
Kim, H. S.,
Kuhn, H.,
Valentinova, N.,
and Chan, L.
(1996)
J. Clin. Invest.
98,
2201-2208[Medline]
[Order article via Infotrieve]
|
| 38.
|
Kuhn, H.,
and Chan, L.
(1997)
Curr. Opin. Lipidol.
8,
111-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Kuhn, H.,
and Borngrabber, S.
(1999)
in
Lipoxygenases and Their Metabolites, Advances in Experimental Medicine and Biology Series
(Nigam, S.
, and Pace-Asciak, C. R., eds), Vol. 447
, pp. 5-28, Plenum Press, New York
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.